首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1575762

全球细胞扩增市场 - 2024-2031

Global Cell Expansion Market - 2024-2031

出版日期: 2024年10月22日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

全球电池扩张市场将于 2023 年达到 200 亿美元，预计到 2031 年将达到 550 亿美元，2024-2031 年预测期间复合年增长率为 15.3%。

细胞扩增是培养分离细胞多代的过程，以获得患者再生反应所需的细胞数量。这涉及在封闭的培养容器中进行连续传代以及使用培养基去除代谢物并提供营养。

此外，细胞扩增是生物技术和再生医学中的关键过程，旨在增加用于治疗应用的特定细胞类型的数量。它对于开发基于细胞的疗法至关重要，例如干细胞和免疫细胞，这些疗法需要大量细胞。细胞扩增的意义在于生产用于癌症免疫治疗、组织工程和再生医学的功能性细胞。

市场动态：

驱动程式和限制

慢性病盛行率上升

由于癌症、糖尿病和自体免疫疾病等慢性疾病的增加，全球细胞扩增市场正在扩大。这导致了对再生医学、细胞疗法和个人化治疗等先进疗法的需求。细胞扩增对于开发这些治疗方法至关重要，医疗保健提供者和研究人员正在寻求创新的解决方案，以满足全球对有效治疗方案的需求。

例如，根据健康指标与评估研究所的数据，到 2023 年，糖尿病将影响全球超过 5 亿人，影响各年龄层的男性、女性和儿童。预计未来 30 年这一数字将翻一番，达到 13 亿，每个国家都会成长。全球盛行率为 6.1%，使糖尿病成为死亡和残疾的十大原因之一。北非和中东的比率最高，为 9.3%，预计到 2050 年将升至 16.8%。

与细胞生物学相关的伦理问题

细胞生物学的伦理问题限制了细胞扩增市场。胚胎干细胞的使用涉及破坏人类胚胎，因此在许多国家受到限制。成体干细胞是一种符合道德的替代方案，通常涉及侵入性操作，引发了对患者同意和安全的担忧。基因改造细胞对患者和环境构成潜在风险。这些道德问题正在阻碍细胞扩增市场的成长。

细分市场分析

全球细胞扩增市场根据产品类型、细胞类型、应用、最终用户和地区进行细分。

此产品类型细分市场的仪器约占细胞扩增市占率的41.3%

产品类型细分市场的工具约占41.3%。仪器对于细胞扩增至关重要，可以实现治疗和研究目的的受控生长和增殖。自动化生物反应器、细胞计数器、离心机和培养箱在细胞培养过程中保持最佳条件，确保一致性、可扩展性和效率。这些设备对于再生医学、免疫疗法和组织工程至关重要。先进的仪器提高了细胞活力和产量，降低了污染风险，并生产出供临床使用的高品质细胞。

例如，2024 年 9 月，10x Genomics, Inc. 推出了 Chromium Xo，这是一款新型单细胞仪器，专为在有限预算内寻求高品质资料的研究人员而设计。这种经济实惠的常规高性能单细胞分析入口是其 Chromium 单细胞仪器系列的一部分。

市场地域占有率

预计北美在整个预测期内将占据总市场份额的 38.4% 左右

由于癌症发病率上升、政府资助增加、干细胞疗法研究以及对先进治疗方法认识的提高，北美在整个预测期内预计将占据约 38.4% 的总市场份额。

例如，2024 年 10 月，开发个人化（自体）细胞疗法的私人生物技术公司 Aspen Neuroscience, Inc. 宣布扩大其位于托利松总部附近的圣地牙哥业务，新建一座 22,000 平方英尺的 GMP 生产设施诱导多能干细胞（iPSC）衍生的细胞疗法。

此外，2024 年 8 月，Pluri Inc 获得了一项使用专有 3D 细胞扩增技术来扩增免疫细胞的新方法的美国专利。此技术模仿人体内免疫细胞的天然淋巴结样环境，为细胞在规模和品质上高效扩张提供必要的条件。

Moreover, cell expansion is a crucial process in biotechnology and regenerative medicine, aiming to increase the quantity of specific cell types for therapeutic applications. It is essential for developing cell-based therapies, such as stem cells and immune cells, which require large numbers of cells. Cell expansion's significance lies in producing functional cells for cancer immunotherapy, tissue engineering, and regenerative medicine.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of chronic diseases

The global cell expansion market is expanding due to the rise in chronic diseases like cancer, diabetes, and autoimmune disorders. This has led to a demand for advanced therapies like regenerative medicine, cell-based therapies, and personalized treatments. Cell expansion is crucial for developing these treatments, and healthcare providers and researchers are seeking innovative solutions to meet the global need for effective treatment options.

For instance, in 2023, according to Institute for Health Metrics and Evaluation, Diabetes affects over half a billion people globally, affecting men, women, and children of all ages. The number is projected to double to 1.3 billion in the next 30 years, with every country experiencing an increase. The global prevalence rate is 6.1%, making diabetes one of the top 10 leading causes of death and disability. North Africa and the Middle East have the highest rate at 9.3%, which is projected to rise to 16.8% by 2050.

Ethical concern related to cell biology

Ethical concerns in cell biology are limiting the cell expansion market. The use of embryonic stem cells, which involve human embryo destruction, has led to restrictions in many countries. Adult stem cells, an ethical alternative, often involve invasive procedures, raising concerns about patient consent and safety. Genetically modified cells pose potential risks to patients and the environment. These ethical concerns are hindering the growth of the cell expansion market.

Market Segment Analysis

The global cell expansion market is segmented based on product type, cell type, application, end user and region.

The instruments from the product type segment accounted for approximately 41.3% of the cell expansion market share

The instruments from the product type segment accounted for approximately 41.3%. Instruments are crucial in cell expansion, enabling controlled growth and multiplication for therapeutic and research purposes. Automated bioreactors, cell counters, centrifuges, and incubators maintain optimal conditions during cell culture, ensuring consistency, scalability, and efficiency. These devices are essential for regenerative medicine, immunotherapy, and tissue engineering. Advanced instrumentation improves cell viability and yield reduces contamination risks, and produces high-quality cells for clinical use.

For instance, in September 2024, 10x Genomics, Inc. launched Chromium Xo, a new single cell instrument designed for researchers seeking high-quality data on limited budgets. This affordable entry point into routine, high-performance single cell analysis is part of its fleet of Chromium single cell instruments.

Market Geographical Share

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to rising cancer incidence, increased government funding, research on stem cell therapies, and increased awareness of advanced treatment methods.

For instance, in October 2024, Aspen Neuroscience, Inc., a private biotechnology company developing personalized (autologous) cell therapies, announced the expansion of its San Diego footprint near its headquarters in Torrey Pines, with a new 22,000 square foot facility for GMP manufacturing of induced pluripotent stem cell (iPSC)-derived cell therapies.

Moreover, in August 2024, Pluri Inc has been granted a US patent for a new method for expanding immune cells using proprietary 3D cell expansion technology. This technology mimics the natural lymph node-like environment of immune cells within the human body, providing cells with the necessary conditions for efficient expansion at scale and quality.

Market Segmentation

By Product Type

Automated Cell Expansion Systems

Instruments

Cell Expansion Supporting Equipment

Cell Counters

Flow Cytometers

Centrifuges

Other Supporting Equipment

Others

Consumables

Reagents

Media

Disposables

Tissue Culture Flasks

Others

Bioreactors

Microcarrier Bioreactors

Microcarrier-based anchorage-dependent bioreactors

Suspension-based anchorage-independent bioreactors

Perfusion/Hollow Fibre Bioreactors

By Cell Type

Animal Cells

Human Cells

Stem Cells (SCs)

Adult Stem Cells

Others

By Application

Regenerative Medicine and Stem Cell Research

Clinical Studies

Vaccine Production

Others

By End User

Biopharmaceutical & Biotechnology Companies

Research Institutes

Hospitals

Diagnostic Laboratories

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Competitive Landscape

The major global players in the market include Thermo Fisher Scientific, Inc, Merck KGaA, Becton, Dickinson and Company, GE Healthcare, Terumo BCT, Beckman Coulter Inc, Miltenyi Biotec, Stemcell Technologies, Inc., Takara Bio Inc., Lnza Group LTD among others.

Key Developments

In August 2024, HC Corporation Biomedical Division showcased a prototype of its new cell expansion system, LiCellGrow, at the ISCT Europe 2024 Regional Meeting in Gothenburg, Sweden. LiCellGrow allows pharmaceutical companies to visualize real-time metabolic changes in cells and automatically adjust cell culture conditions for optimal growth. It aims to increase the availability of cell and gene therapy products by accelerating the manufacturing of specific cells needed for these therapies.

In March 2024, Getinge has partnered with the bioprocessing company CellRev in the development of a continuous cell processing platform called Livit ACE (Adherent Cell Expansion). The solution is a breakthrough within allogenic cell therapy manufacturing.

Why Purchase the Report?

To visualize the global cell expansion market segmentation based on product type, cell type, application, end user and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the cell expansion market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global cell expansion market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Cell Type
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the prevalence of chronic diseases
  - 4.1.1.2. Rise in the advancements of devices
- 4.1.2. Restraints
  - 4.1.2.1. Ethical concern related to cell biology
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Automated Cell Expansion Systems*
- 6.2.1. Introduction
6.3. Instruments
6.4. Consumables
6.5. Bioreactors

7. By Cell Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
7.2. Market Attractiveness Index, By Cell Type
7.3. Animal Cells*
- 7.3.1. Introduction
- 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.4. Human Cells
7.5. Stem Cells (SCs)
7.6. Adult Stem Cells
7.7. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.2. Market Attractiveness Index, By Application
8.3. Regenerative Medicine and Stem Cell Research*
- 8.3.1. Introduction
- 8.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.4. Clinical Studies
8.5. Vaccine Production
8.6. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Biopharmaceutical & Biotechnology Companies*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Research Institutes
9.4. Hospitals
9.5. Diagnostic Laboratories
9.6. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. UK
  - 10.3.7.3. France
  - 10.3.7.4. Italy
  - 10.3.7.5. Spain
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Thermo Fisher Scientific, Inc*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Merck KGaA
12.3. Becton, Dickinson and Company
12.4. GE Healthcare
12.5. Terumo BCT
12.6. Beckman Coulter Inc
12.7. Miltenyi Biotec
12.8. Stemcell Technologies, Inc.
12.9. Takara Bio Inc.
12.10. Lnza Group LTD (*LIST NOT EXHAUSTIVE)